Evidence map›Paper›PMID 37103391›Full record

ArticleMarine drugs2023

Belén Cuevas, Ana I Arroba, Carolina de Los Reyes, Eva Zubía

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Marine drugs, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.1field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. The Ocean's Pharmacy: Health Discoveries in Marine Algae.Molecules (Basel, Switzerland) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Belén CuevasDepartamento de Química Orgánica, Facultad de Ciencias del Mar y Ambientales, Universidad de Cádiz, 11510 Puerto Real (Cádiz), Spain.ORCID 0000-0002-7667-0751
Ana I ArrobaUnidad de Investigación, Instituto de Investigación e Innovación Biomédica de Cádiz (INiBICA), Hospital Universitario Puerta del Mar, Avda. Ana de Viya 21, 11009 Cádiz, Spain.ORCID 0000-0002-5136-1725
Carolina de Los ReyesDepartamento de Química Orgánica, Facultad de Ciencias del Mar y Ambientales, Universidad de Cádiz, 11510 Puerto Real (Cádiz), Spain.
Eva ZubíaDepartamento de Química Orgánica, Facultad de Ciencias del Mar y Ambientales, Universidad de Cádiz, 11510 Puerto Real (Cádiz), Spain.
Universidad de Cádiz · ES

Funding

Junta de Andalucía, Spain (ITI-FEDER research projects) ITI-0012-2019
6 · The paper itself

Abstract

This study aimed to evaluate the anti-inflammatory potential of the different classes of diterpenoids produced by algae of the genus

Indexed as

DiterpenesNitric OxideAnimalsAnti-Inflammatory AgentsLipopolysaccharidesMacrophagesMiceRAW 264.7 CellsAnti-Inflammatory AgentsDiterpenesLipopolysaccharidesNitric Oxideanti-inflammatorybrown algaediterpenoidsNO inhibitionRugulopteryx okamurae

Identifiers

PMID37103391
PMCPMC10142882
OpenAlexW4366729653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.